GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
SBHAX
Price
$18.00
Change
-$0.79 (-4.20%)
Updated
Apr 3 closing price
Net Assets
92.41M
Ad is loading...

GFACX vs SBHAX

Header iconGFACX vs SBHAX Comparison
Open Charts GFACX vs SBHAXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
Segall Bryant & Hamill All Cap Instl
Price$18.00
Change-$0.79 (-4.20%)
VolumeN/A
Net Assets92.41M
GFACX vs SBHAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. SBHAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and SBHAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. SBHAX (92.4M). SBHAX pays higher dividends than GFACX: SBHAX (0.23) vs GFACX (0.00). GFACX was incepted earlier than SBHAX: GFACX (24 years) vs SBHAX (12 years). GFACX (1.36) is less costly to investors than SBHAX (0.91). GFACX is a more actively managed with annual turnover of: 25.00 vs. SBHAX (21.00). GFACX has a lower initial minimum investment than SBHAX: GFACX (250) vs SBHAX (250000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. SBHAX (-12.46). GFACX return over 5 years is better than : 59.73 vs. SBHAX (42.15).
GFACXSBHAXGFACX / SBHAX
Total Expense Ratio1.360.84162%
Annual Report Gross Expense Ratio1.360.91149%
Fund Existence24 years12 years-
Gain YTD-5.003-3.789132%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets280B92.4M303,030%
Annual Yield % from dividends0.000.23-
Returns for 1 year-1.75-12.4614%
Returns for 3 years0.63-15.25-4%
Returns for 5 years59.7342.15142%
Returns for 10 years44.4659.1175%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences